The U.S. Food and Drug Administration has approved bremelanotide (Brand Name: Vyleesi) to treat acquired,…
Advertisements
FDA
Tonix Pharmaceuticals announced the expansion of the TNX-102 SL 5.6 mg program beyond posttraumatic stress…
U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for SEP-363856, a novel…
The U.S. Food and Drug Administration today announced the agency is requiring a new boxed…
US FDA Approves Brexanolone (ZULRESSO) -First Treatment for Post-Partum Depression The U.S. Food and Drug…
The U.S. Food and Drug Administration has approved Spravato (esketamine) nasal spray, in conjunction with…
Gelesis, a biotechnology company developing first-in-class hydrogel therapeutics to treat obesity and other chronic diseases…
Swiss drugmaker Novartis has received US approval for its spinal muscular atrophy gene therapy Zolgensma…
The FDA cleared the -Cervella™ Cranial Electrotherapy Stimulator- medical device for treatment of anxiety, depression,…
The U.S. Food and Drug Administration today permitted marketing of the first medical device to…
The U.S. Food and Drug Administration issued a warning letter to Inova Genomics Laboratory (Inova)…
The U.S. Food and Drug Administration today posted a warning letter to Nutra Pharma Corp….
